G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $454,274 | +818.4% | 105,156 | +548.4% | 0.00% | – |
Q4 2023 | $49,465 | +168.0% | 16,218 | +26.6% | 0.00% | – |
Q3 2023 | $18,454 | -74.9% | 12,815 | -53.3% | 0.00% | – |
Q1 2023 | $73,579 | -72.5% | 27,455 | -44.3% | 0.00% | -100.0% |
Q4 2022 | $267,775 | -55.5% | 49,314 | +2.4% | 0.00% | -66.7% |
Q3 2022 | $602,000 | +484.5% | 48,181 | +130.2% | 0.00% | +200.0% |
Q2 2022 | $103,000 | +9.6% | 20,926 | +69.9% | 0.00% | – |
Q1 2022 | $94,000 | -38.2% | 12,319 | -17.0% | 0.00% | – |
Q4 2021 | $152,000 | -25.9% | 14,839 | +59.0% | 0.00% | -100.0% |
Q2 2021 | $205,000 | -4.2% | 9,332 | -21.7% | 0.00% | -50.0% |
Q4 2020 | $214,000 | -82.3% | 11,919 | -88.6% | 0.00% | -87.5% |
Q3 2020 | $1,207,000 | +135.3% | 104,468 | +393.7% | 0.02% | +100.0% |
Q2 2020 | $513,000 | -15.5% | 21,160 | -61.6% | 0.01% | -50.0% |
Q1 2020 | $607,000 | +17.0% | 55,084 | +180.8% | 0.02% | +433.3% |
Q4 2019 | $519,000 | -30.7% | 19,618 | -40.3% | 0.00% | -57.1% |
Q3 2019 | $749,000 | +258.4% | 32,871 | +383.1% | 0.01% | +250.0% |
Q2 2019 | $209,000 | -82.5% | 6,804 | -89.1% | 0.00% | -85.7% |
Q4 2018 | $1,192,000 | -25.8% | 62,233 | +102.5% | 0.01% | -26.3% |
Q3 2018 | $1,607,000 | +102.1% | 30,735 | +68.0% | 0.02% | +72.7% |
Q2 2018 | $795,000 | – | 18,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |